Zosano Pharma Corp (ZSAN) was Downgraded by Ladenburg Thalmann to ” Neutral”. Earlier the firm had a rating of “Buy ” on the company shares. Ladenburg Thalmann advised their investors in a research report released on Aug 11, 2016.
Zosano Pharma Corp closed down -0.03 points or -1.99% at $1.48 with 4,241 shares getting traded on Monday. Post opening the session at $1.54, the shares hit an intraday low of $1.45 and an intraday high of $1.54 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers rapid onset consistent drug delivery and improved ease of use and room-temperature stability. Its microneedle patch system has the potential to deliver numerous medications for a range of indications in commercially attractive markets. The Company’s short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an existing drug and attached to an adhesive patch. Its lead product candidates and the indications they are expected to treat include Daily ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan for migraine.